Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 25
1973 65
1974 105
1975 65
1976 76
1977 101
1978 63
1979 74
1980 82
1981 53
1982 78
1983 92
1984 71
1985 54
1986 44
1987 39
1988 43
1989 39
1990 43
1991 33
1992 22
1993 15
1994 8
1995 11
1996 11
1997 21
1998 21
1999 41
2000 43
2001 70
2002 101
2003 110
2004 247
2005 268
2006 276
2007 342
2008 345
2009 307
2010 337
2011 287
2012 224
2013 275
2014 324
2015 306
2016 323
2017 373
2018 367
2019 326
2020 276
2021 300
2022 297
2023 191
2024 258
2025 232
2026 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,569 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of cerebral venous thrombosis: a review.
Patel H, Lunn I, Hameed S, Khan M, Siddiqui FM, Borhani A, Majid A, Bell SM, Wasay M. Patel H, et al. Curr Med Res Opin. 2024 Dec;40(12):2223-2236. doi: 10.1080/03007995.2024.2423740. Epub 2024 Nov 8. Curr Med Res Opin. 2024. PMID: 39492709 Free article. Review.
Comorbidities of hypothyroidism.
Brenta G, Gottwald-Hostalek U. Brenta G, et al. Curr Med Res Opin. 2025 Mar;41(3):421-429. doi: 10.1080/03007995.2025.2476075. Epub 2025 Mar 12. Curr Med Res Opin. 2025. PMID: 40066580 Free article. Review.
Evaluating the safety profile of semaglutide: an updated meta-analysis.
Rivera FB, Arias-Aguirre E, Aguirre Z, Ybañez MJC, Rubia JMM, Galang DJ, Lumbang GN, Ruyeras JMMJ, Magalong JV, Pine PL, Amigo JAC, Ansay MFM, Zelenkov N, Thomas SS, Vijayaraghavan K. Rivera FB, et al. Curr Med Res Opin. 2024 Sep;40(9):1495-1514. doi: 10.1080/03007995.2024.2383731. Epub 2024 Jul 27. Curr Med Res Opin. 2024. PMID: 39046272
Editorial.
Matheis RJ, Stothard D. Matheis RJ, et al. Curr Med Res Opin. 2025;41(sup1):2-3. doi: 10.1080/03007995.2025.2488632. Epub 2025 May 10. Curr Med Res Opin. 2025. PMID: 40349099 Free article. No abstract available.
Efficacy and safety of lebrikizumab combined with topical corticosteroids in Japanese patients with moderate-to-severe atopic dermatitis: a phase 3, double-blind, placebo-controlled, randomized clinical trial (ADhere-J).
Katoh N, Tanaka A, Takahashi H, Shimizu R, Kataoka Y, Torisu-Itakura H, Morisaki Y, Igawa K. Katoh N, et al. Curr Med Res Opin. 2025 Jan;41(1):1-12. doi: 10.1080/03007995.2024.2436982. Epub 2024 Dec 13. Curr Med Res Opin. 2025. PMID: 39625230 Free article. Clinical Trial.
Correction.
[No authors listed] [No authors listed] Curr Med Res Opin. 2024 Oct;40(10):1827-1828. doi: 10.1080/03007995.2024.2401192. Epub 2024 Sep 17. Curr Med Res Opin. 2024. PMID: 39287157 No abstract available.
7,569 results